Literature DB >> 10614688

Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.

D F Lewis1, B G Lake, S G George, M Dickins, P J Eddershaw, M H Tarbit, A P Beresford, P S Goldfarb, F P Guengerich.   

Abstract

Molecular modelling of a number of CYP1 family enzymes from rat, plaice and human is described based on amino acid sequence homology with the haemoprotein domain of CYP102, a unique bacterial P450 of known structure. The interaction of various substrates and inhibitors within the putative active sites of rat CYP1A1, human CYP1A2, a fish CYP1 enzyme CYP1A6 (from plaice) and human CYP1B1, is shown to be consistent with P450-mediated oxidation in each example or, in the case of inhibitors, mechanism of inhibition. It is reported that relatively small changes between the enzymes' active site regions assist in the rationalization of CYP1 enzyme preferences for particular substrate types, and a template of superimposed CYP1A2 substrates is shown to fit the putative active site of the human CYP1A2 enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614688     DOI: 10.1016/s0300-483x(99)00098-0

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  6 in total

1.  Gene structure and comparative and phylogenetic analyses of Catla catla CYP1A full-length cDNA and its responsiveness to benzo(a)pyrene and copper sulphate at early developmental stages.

Authors:  Kavita Kumari; Gireesh-Babu Pathakota; Shivendra Kumar; Gopal Krishna
Journal:  Fish Physiol Biochem       Date:  2017-08-19       Impact factor: 2.794

2.  ZNF165 Is Involved in the Regulation of Immune Microenvironment and Promoting the Proliferation and Migration of Hepatocellular Carcinoma by AhR/CYP1A1.

Authors:  Peng Liu; Yan Zhou; Xin Dong; Biao Zheng; Bo Liang; Rui Liang; Zhong Liu; Li Li; Peng Gong
Journal:  J Immunol Res       Date:  2022-06-01       Impact factor: 4.493

3.  PCB153 and p,p'-DDE disorder thyroid hormones via thyroglobulin, deiodinase 2, transthyretin, hepatic enzymes and receptors.

Authors:  Changjiang Liu; Mei Ha; Lianbing Li; Kedi Yang
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-01       Impact factor: 4.223

4.  Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.

Authors:  David F V Lewis
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

5.  In Silico ADME, Metabolism Prediction and Hydrolysis Study of Melatonin Derivatives.

Authors:  Panyada Panyatip; Nadtanet Nunthaboot; Ploenthip Puthongking
Journal:  Int J Tryptophan Res       Date:  2020-12-15

Review 6.  Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors.

Authors:  Zbigniew Dutkiewicz; Renata Mikstacka
Journal:  Bioinorg Chem Appl       Date:  2018-07-25       Impact factor: 7.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.